Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,612 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,035
Recruiting: 592
Ph III recruiting: 61
Growth YoY: +8.1%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (801)

clinicaltrialsPublishedShowing 201–250 of 709 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03934372	Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors	recruiting	Phase 1 / Phase 2	70	Incyte Biosciences International SàrlINDUSTRY	7	Jul 23, 2026	clinicaltrials
NCT05350748	Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS	recruiting	—	1,100	National Cancer Institute (NCI)NIH	1	Jul 23, 2026